LEADER 02924nam 2200673 450 001 9910713778703321 005 20200724114820.0 035 $a(CKB)5470000002503894 035 $a(OCoLC)1176566875 035 $a(EXLCZ)995470000002503894 100 $a20200724d2013 ua 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCooperative amphibian monitoring protocol for the Greater Yellowstone Network$iStandard operating procedures$fRobert Bennetts [and seven others, Amphibian Monitoring Working Group] 210 1$aFort Collins, Colorado :$cU.S. Department of the Interior, National Park Service, Natural Resource Stewardship and Science,$d2013. 215 $a1 online resource (86 pages in various pagings) $ccolor illustrations, color map 225 1 $aNatural resource report ;$vNPS/GRYN/NRR--2013/655 300 $a"NPS 960/120502, April 2013"--Page iii. 300 $a"Experience your America"--Page 4 of cover. 300 $aIncludes tables. 320 $aIncludes bibliographical references. 606 $aAmphibians$zWyoming$zJohn D. Rockefeller, Jr., Memorial Parkway 606 $aAmphibians$zWyoming$zGrand Teton National Park 606 $aAmphibians$zYellowstone National Park 606 $aAmphibians$xMonitoring$zWyoming$zJohn D. Rockefeller, Jr., Memorial Parkway 606 $aAmphibians$xMonitoring$zWyoming$zGrand Teton National Park 606 $aAmphibians$xMonitoring$zYellowstone National Park 606 $aClimatic changes$zWyoming$zJohn D. Rockefeller, Jr., Memorial Parkway 606 $aClimatic changes$zWyoming$zGrand Teton National Park 606 $aClimatic changes$zYellowstone National Park 606 $aEnvironmental monitoring$zWyoming$zJohn D. Rockefeller, Jr., Memorial Parkway 606 $aEnvironmental monitoring$zWyoming$zGrand Teton National Park 606 $aEnvironmental monitoring$zYellowstone National Park 607 $aJohn D. Rockefeller, Jr., Memorial Parkway (Wyo.) 607 $aGrand Teton National Park (Wyo.) 607 $aYellowstone National Park 615 0$aAmphibians 615 0$aAmphibians 615 0$aAmphibians 615 0$aAmphibians$xMonitoring 615 0$aAmphibians$xMonitoring 615 0$aAmphibians$xMonitoring 615 0$aClimatic changes 615 0$aClimatic changes 615 0$aClimatic changes 615 0$aEnvironmental monitoring 615 0$aEnvironmental monitoring 615 0$aEnvironmental monitoring 700 $aBennetts$b Robert E.$01395027 712 02$aUnited States.$bNational Park Service.$bNatural Resource Stewardship and Science, 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910713778703321 996 $aCooperative amphibian monitoring protocol for the Greater Yellowstone Network$93452971 997 $aUNINA LEADER 05282oam 2200661I 450 001 9910800080403321 005 20230725050549.0 010 $a0-429-14713-9 010 $a1-4398-1687-5 024 7 $a10.1201/b10852 035 $a(CKB)2550000000039620 035 $a(EBL)726848 035 $a(OCoLC)735601951 035 $a(SSID)ssj0000520987 035 $a(PQKBManifestationID)11336105 035 $a(PQKBTitleCode)TC0000520987 035 $a(PQKBWorkID)10517703 035 $a(PQKB)11120664 035 $a(MiAaPQ)EBC726848 035 $a(Au-PeEL)EBL726848 035 $a(CaPaEBR)ebr10479216 035 $a(CaONFJC)MIL693700 035 $a(EXLCZ)992550000000039620 100 $a20180331d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aArthritis $epathophysiology, prevention, and therapeutics /$fedited by Debasis Bagchi, Hiroyoshi Moriyama, and Siba P. Raychaudhuri 210 1$aBoca Raton :$cCRC Press,$d2011. 215 $a1 online resource (586 p.) 300 $aDescription based upon print version of record. 311 $a1-322-62418-6 311 $a1-4398-1686-7 320 $aIncludes bibliographical references and index. 327 $aFront Cover; Contents; Preface; Editors; Contributors; Chapter 1: An Overview on Rheumatologic Disorders; Chapter 2: Pathogenesis of Osteoarthritis; Chapter 3: Biomarkers in Osteoarthritis; Chapter 4: Rheumatoid Arthritis : Disease Pathophysiology; Chapter 5: Osteoclasts and Interleukin-17-Producing Helper T Cells in Rheumatoid Arthritis; Chapter 6: WNT/ß-Catenin Signaling Modulating Osteoarthritis; Chapter 7: Psoriatic Arthritis : Epidemiology, Risk Factors, and Quality of Life; Chapter 8: Arthritis, Obesity, Increased Cardiovascular Risk, and Disability 327 $aChapter 9: An Overview : Use of Traditional Antiarthritic Drugs and Update on Drug DevelopmentChapter 10: Nonsteroidal Anti-Inflammatory Drugs; Chapter 11: Biologics : Target-Specific Treatment of Systemic and Cutaneous Autoimmune Diseases; Chapter 12: Topical Applications for Pain and Arthritic Diseases; Chapter 13: Hyaluronic Acid and Arthritis : A Review; Chapter 14: Hyaluronan for the Treatment of Osteoarthritis and Rheumatoid Arthritis; Chapter 15: Immunomodulatory Activities of Japanese Traditional Medicines in Rheumatoid Arthritis 327 $aChapter 16: An Overview on Natural Therapeutic InterventionsChapter 17: Potential Health Benefits from Nutrition and Dietary Supplements in the Prevention of Osteoarthritis and Rheumatoid; Chapter 18: Antiarthritic Potential of Glucosamine and Chondroitin : An Overview; Chapter 19: An Overview on N-Acetylglucosamine and Arthritis; Chapter 20: Hexosamine Flux and the Efficacy and Safety of Glucosamine in the Treatment of Osteoarthritis; Chapter 21: Safety and Efficacy of a Unique Undenatured Type II Collagen in the Treatment of Arthritis 327 $aTargeting Inflammatory Pathways by Nutraceuticals for Prevention and Treatment of ArthritisChapter 23: Boswellia serrata for Arthritis Relief : A Journey from Frankincense to Aflapin and 5-Loxin; Chapter 24: Utilization of Marine Products in the Treatment and Prevention of Osteoarthritis; Chapter 25: Benefits of Fish Oil for Rheumatoid Arthritis : A Review; Chapter 26: Potential Health Benefits of n-3 and -6 Fatty Acids in Selected Plant Seed Oils in Rheumatoid Arthritis; Chapter 27: Antiarthritic Potential of Bromelain from Ananas comosus and Its Combination 327 $aChapter 28: Anti-Inflammatory Properties of Zingiber officinale var. Rubra (Red Ginger Extract)Chapter 29: Benefits of Radix Tripterygium wilfordii for Rheumatoid Arthritis; Chapter 30: Dehydroepiandrosterone (DHEA) : A Review of Its Preclinical Use in the Management of Osteoarthritis; Chapter 31: Antiarthritic Potential of Green-Lipped Mussel and Other Marine-Based Nutraceuticals; Chapter 32: Antioxidant, Anti-Inflammatory, and Anticatabolic Potential of Rosmarinic Acid and High-Rosmarinic Acid Mint (Menth 327 $aChapter 33: Potential Health Benefits of Orally Administered Hyaluronan in Alleviating Knee Joint Pain 330 $aA debilitating disease of pain, inflammation, and loss of mobility and quality of life, arthritis takes victims of all ages, from young children to seniors. Usually chronic, the broad term arthritis refers to nearly 100 distinct manifestations, each with their own etiology, pathophysiology, and treatment. With medical research getting so much attention, it is no wonder there have been recent leaps in the investigation into arthritis treatment. It is important to have a high quality, trusted compendium to capture the breadth and depth of new information in the field.Covering cutting-e 606 $aArthritis$xPathophysiology 606 $aArthritis$xTreatment 615 0$aArthritis$xPathophysiology. 615 0$aArthritis$xTreatment. 676 $a616.7/22 701 $aBagchi$b Debasis$f1954-$0857473 701 $aMoriyama$b Hiroyoshi$01587846 701 $aRaychaudhuri$b Siba P$01519247 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910800080403321 996 $aArthritis$93876413 997 $aUNINA